The Slow Drift Toward Variability and the Case for Standardization
Teams in mid-phase development often look back at their operational processes and see that they carry the imprint of every decision made along the way. Early work is frequently shaped by the conditions that existed at the time, like the availability of a particular kit in one geography, the comfort a given site had with handling collections a specific way, or an approach to cryopreservation that solved an immediate scheduling issue (but never became the model for the rest of the program). No single choice felt significant in the moment, and each helped to keep the program moving. But as more sites are added and new regions open, the one-off decisions made along the way become part of a broader system that begins to show its variability as the program expands.
This becomes especially clear for teams preparing for IND or when a program is getting ready for a larger geographic footprint. Where the operational record fails to demonstrate a single, continuous process and instead reflects how the program grew, piece by piece, with each site or vendor bringing its own habits and interpretations, is the point at which regulatory reviewers – who are unlikely to flag any single discrepancy on its own – will see signals that the overarching system isn’t behaving in a stable, predictable way. When this happens, teams often find themselves trying to explain the history behind the various early-stage decisions they barely remember making.
Growth eventually exposes inconsistencies. These choices weren’t wrong; they simply accumulate. But their combined effect becomes visible as the program grows. Standardization becomes the mechanism for bringing the workflow back into alignment so that the next phase is built on a stable foundation rather than a patchwork of well-intended exceptions.
Where Variability Starts to Influence the System
As programs mature, these small details begin to carry more weight. A collection kit sourced by one site through its own channels may look almost identical to one used elsewhere, but subtle differences in components can influence how materials are handled… cryopreservation is done onsite immediately following collection, but one center may use its own timing for cooling profiles, while another region relies on a centralized process that follows a defined sequence. A series of small procedural habits are the natural byproduct of uneven growth across multiple partners and locations.
What becomes difficult downstream is demonstrating how these variations fit within the program as a whole. In the early phases, it’s easy to assume that each site’s interpretation of a task is still close enough to the intended process. But as more partners enter the picture, the combined effect of this variability becomes more impactful as the supply chain begins to behave less like a unified, single system and more like a collection of parallel approaches that happen to share a protocol.
This is usually where operational teams start to feel the strain. Not because something has failed, necessarily, but because they start to see how difficult it will be to defend this complexity later.
Regulatory Preparation Shines a Spotlight on These Differences
When teams begin their regulatory preparation, all these different choices reveal the reality of an inconsistent approach that has been there all along but hasn’t been clear until now. That site’s preferred version of a collection kit, for example, differs just enough from the standard version that the team now needs to document the reasoning behind the variation. Or the decision to cryopreserve locally now needs to be explained, since the rest of the program uses a centralized method.
While regulators don’t expect complete uniformity, they do expect validated comparability where processes diverge. If the operational processes allow for many different paths that all lead to the same endpoint, for example, the team preparing for regulatory filings and reviews must now create a narrative that explains the divergence and supports the consistency of the outcome. Not only does this take time, but the process can often uncover decisions that were never fully evaluated when they were made because they were decided quickly, in a silo, to solve an immediate operational need.
The decisions that were made in the name of flexibility during early growth now create a set of inconsistencies that don’t always map cleanly to a single, intentional process. The work of preparing for review in these cases quickly becomes a process of retroactive alignment instead of simply assembling the evidence.
Standardization Strengthens the Foundation
Standardization across the full end-to-end supply chain, including cryopreservation of starting materials, kitting, biostorage, shipping, and even secondary packaging and labeling, allows teams to adopt an integrated approach that holds across geographies and at scale.
Teams often begin this work by trying to streamline their processes, but frequently find they need a clearer understanding of where true sources of variability lie. Consulting and advisory support can help to expose those areas. Risk assessments can highlight where certain procedures or routes carry more unpredictability than expected. Lane qualification programs document how routes perform under both normal and stressed conditions. Shipping system and packaging validations confirm that the materials protecting the therapy behave predictably across environments and geographies.
These activities do more than satisfy regulatory expectations, although they do provide robust documentation in support of filings. They give teams clarity about why certain decisions make sense, and why others create avoidable risk. When the reasoning behind the full workflow is well-supported, the program no longer relies on institutional memory to explain its choices. Reviewers respond positively to this clarity, since it demonstrates that the program not only understands its own mechanics but also has evaluated them with the same rigor applied to the science of the therapy.
Integration Reduces the Hidden Costs of Fragmentation
Fragmentation is often the product of many different reasonable decisions made in isolation. Various vendors are selected for each step of the supply chain, sometimes multiple vendors for a given need (based on proximity and regionality), creating a network of independent workflows that lack shared standards or documentation.
Integration closes those gaps. A single partner, such as Cryoport Systems, that provides cryopreservation, kitting, biostorage, and logistics under a single framework, provides the program with a consistent foundation across all sites. Not only does this streamline regulatory filings and reviews, but it also provides a framework that continues to hold as new regions or partners are added. As new sites or regions come online, they enter a well-defined system with clear expectations that match what has already been established and validated.
As programs advance, standardization becomes less about enforcing uniformity and more about building an integrated supply chain that behaves reliably under the pressure of scale. The habits and workarounds of early phases do not always translate into regulatory success. By creating consistency and reducing fragmentation through an integrated partner model, programs position themselves to move through subsequent stages with fewer surprises and a steady foundation.
What teams discover is that standardization is not a constraint. It reflects a kind of foresight that streamlines growth and simplifies regulatory engagement.
